<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DDI-DrugBank.d305">
    <sentence id="DDI-DrugBank.d305.s0" text="Dantrium is metabolized by the liver, and it is theoretically possible that its metabolism may be enhanced by drugs known to induce hepatic microsomal enzymes.">
        <entity charOffset="0-7" id="DDI-DrugBank.d305.s0.e0" text="Dantrium" type="brand"/>
    </sentence>
    <sentence id="DDI-DrugBank.d305.s1" text="However, neither phenobarbital nor diazepam appears to affect Dantrium metabolism.">
        <entity charOffset="17-29" id="DDI-DrugBank.d305.s1.e0" text="phenobarbital" type="drug"/>
        <entity charOffset="35-42" id="DDI-DrugBank.d305.s1.e1" text="diazepam" type="drug"/>
        <entity charOffset="62-69" id="DDI-DrugBank.d305.s1.e2" text="Dantrium" type="brand"/>
        <pair ddi="false" e1="DDI-DrugBank.d305.s1.e0" e2="DDI-DrugBank.d305.s1.e1" id="DDI-DrugBank.d305.s1.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d305.s1.e0" e2="DDI-DrugBank.d305.s1.e2" id="DDI-DrugBank.d305.s1.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d305.s1.e1" e2="DDI-DrugBank.d305.s1.e2" id="DDI-DrugBank.d305.s1.p2"/>
    </sentence>
    <sentence id="DDI-DrugBank.d305.s2" text="Binding to plasma protein is not significantly altered by diazepam, diphenylhydantoin, or phenylbutazone.">
        <entity charOffset="58-65" id="DDI-DrugBank.d305.s2.e0" text="diazepam" type="drug"/>
        <entity charOffset="68-84" id="DDI-DrugBank.d305.s2.e1" text="diphenylhydantoin" type="drug"/>
        <entity charOffset="90-103" id="DDI-DrugBank.d305.s2.e2" text="phenylbutazone" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d305.s2.e0" e2="DDI-DrugBank.d305.s2.e1" id="DDI-DrugBank.d305.s2.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d305.s2.e0" e2="DDI-DrugBank.d305.s2.e2" id="DDI-DrugBank.d305.s2.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d305.s2.e1" e2="DDI-DrugBank.d305.s2.e2" id="DDI-DrugBank.d305.s2.p2"/>
    <negationtags>Binding to plasma protein is &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; significantly altered by diazepam, diphenylhydantoin, or phenylbutazone. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d305.s3" text="Binding to plasma proteins is reduced by warfarin and clotibrate and increased by tolbutamide.">
        <entity charOffset="41-48" id="DDI-DrugBank.d305.s3.e0" text="warfarin" type="drug"/>
        <entity charOffset="82-92" id="DDI-DrugBank.d305.s3.e1" text="tolbutamide" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d305.s3.e0" e2="DDI-DrugBank.d305.s3.e1" id="DDI-DrugBank.d305.s3.p0"/>
    </sentence>
    <sentence id="DDI-DrugBank.d305.s4" text="Cardiovascular collapse in patients treated simultaneously with varapamil and dantrolene sodium is rare.">
        <entity charOffset="78-94" id="DDI-DrugBank.d305.s4.e0" text="dantrolene sodium" type="drug"/>
    </sentence>
    <sentence id="DDI-DrugBank.d305.s5" text="The combination of therapeutic doses of intravenous dantrolene sodium and verapamil in halothane a-chloralose anesthetized swine has resulted in ventricular fibrillation and cardiovascular collapse in association with marked hyperkalemia.">
        <entity charOffset="52-68" id="DDI-DrugBank.d305.s5.e0" text="dantrolene sodium" type="drug"/>
        <entity charOffset="74-82" id="DDI-DrugBank.d305.s5.e1" text="verapamil" type="drug"/>
        <entity charOffset="87-95" id="DDI-DrugBank.d305.s5.e2" text="halothane" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d305.s5.e0" e2="DDI-DrugBank.d305.s5.e1" id="DDI-DrugBank.d305.s5.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d305.s5.e0" e2="DDI-DrugBank.d305.s5.e2" id="DDI-DrugBank.d305.s5.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d305.s5.e1" e2="DDI-DrugBank.d305.s5.e2" id="DDI-DrugBank.d305.s5.p2"/>
    </sentence>
    <sentence id="DDI-DrugBank.d305.s6" text="It is recommended that the combination of intravenous dantrolene sodium and calcium channel blockers, such as verapamil, not be used together during the management of malignant hyperthermia crisis until the relevance of these findings to humans is established.">
        <entity charOffset="54-70" id="DDI-DrugBank.d305.s6.e0" text="dantrolene sodium" type="drug"/>
        <entity charOffset="76-99" id="DDI-DrugBank.d305.s6.e1" text="calcium channel blockers" type="group"/>
        <entity charOffset="110-118" id="DDI-DrugBank.d305.s6.e2" text="verapamil" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d305.s6.e0" e2="DDI-DrugBank.d305.s6.e1" id="DDI-DrugBank.d305.s6.p0" type="advise"/>
        <pair ddi="true" e1="DDI-DrugBank.d305.s6.e0" e2="DDI-DrugBank.d305.s6.e2" id="DDI-DrugBank.d305.s6.p1" type="advise"/>
        <pair ddi="false" e1="DDI-DrugBank.d305.s6.e1" e2="DDI-DrugBank.d305.s6.e2" id="DDI-DrugBank.d305.s6.p2"/>
    <negationtags>It is recommended that the combination of intravenous dantrolene sodium and calcium channel blockers, such as verapamil, &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; be used together during the management of malignant hyperthermia crisis until the relevance of these findings to humans is established. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d305.s7" text="Administration of dantrolene may potentiate vecuronium-induced neuromuscular block.">
        <entity charOffset="18-27" id="DDI-DrugBank.d305.s7.e0" text="dantrolene" type="drug"/>
        <entity charOffset="44-53" id="DDI-DrugBank.d305.s7.e1" text="vecuronium" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d305.s7.e0" e2="DDI-DrugBank.d305.s7.e1" id="DDI-DrugBank.d305.s7.p0" type="effect"/>
    </sentence>
</document>